Overview (18 Sep 2026)
Alivus Life Sciences Ltd
ALIVUS
INE03Q201024

Pharmaceuticals
Result was last declared on 14 May 2026
43

Prev. Close
Previous Close
1387.8
Current Close
1430.8
Current High
1443
Current Low
1387
52 Week High
1493.8
52 Week Low
830
Resistance 1
1453.54
Resistance 2
1476.27
Support 1
1397.54
Support 2
1341.54
Std Deviation
6.09%
DMA 200
1059.07
DMA 50
1297.03
DMA 20
1383.23
Fundamentals and Ratios
Standalone
Trailing EPS
45.99
Forwad EPS
51.36
Trailing P/E
31.11
Forward P/E
27.86
PEG Ratio
4.28
Mkt. Cap (Cr)
Market Cap (Cr)
17561.56
Total Debt(Cr)
Tot. Debt(Cr)
0.00
Reserve (Cr)
3307.59
Book Value
271.35
P/BV Ratio
5.27
ROCE(%)
24.00
ROE
24.00

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue640.41689.12672.89587.98601.852551.83
Other Income22.4022.7813.9314.728.9960.41
Total Income662.82711.90686.82602.70610.832612.24
Interest1.311.311.491.321.255.37
Expenditure-450.59-496.10-462.77-428.56-447.85-1835.28
PBDT0.000.000.000.000.000.00
Depreciation-20.59-20.20-19.66-18.44-17.06-75.36
PBT212.22215.80198.39174.14162.98751.31
Tax-52.15-53.14-48.13-44.11-41.45-186.83
Equity24.5524.5524.540.0024.5324.55
OPM32.0230.3128.8929.6226.6828.76
Net Profit160.08162.66150.26130.03121.54564.48
NPM24.1522.8521.8822.1119.921.61
EPS13.0413.2312.2510.69.9145.99
Consolidated
TypeFY25-26
Revenue2551.83
Other Income60.41
Total Income2612.24
Interest5.37
Expenditure-1835.28
PBDT0.00
Depreciation-75.36
PBT751.31
Tax-186.83
Equity24.55
OPM28.76
Net Profit564.48
NPM21.61
EPS45.99
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2026Final Dividend5.00Final Dividend - Rs. - 5.000001 Sep 2026
2025Final Dividend5.00Final Dividend - Rs. - 5.000001 Sep 2025
2024Interim Divvidend22.50Interim Dividend - Rs. - 22.500017 Oct 2023
2023Interim Divvidend21.00Interim Dividend - Rs. - 21.000024 Mar 2023
Bonus
Split

Mutual Fund Holddings